Kala Bio Inc [KALA] stock prices are down -4.27% to $1.57 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The KALA shares have gain 15.44% over the last week, with a monthly amount drifted -88.79%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kala Bio Inc [NASDAQ: KALA] stock has seen the most recent analyst activity on September 30, 2025, when Mizuho downgraded its rating to a Neutral but kept the price target unchanged to $1.50 for it. Previously, Ladenburg Thalmann downgraded its rating to Neutral on September 29, 2025. On September 29, 2025, downgrade downgraded it’s rating to Neutral. Mizuho started tracking the stock assigning a Outperform rating and suggested a price target of $30 on September 08, 2025. Ladenburg Thalmann initiated its recommendation with a Buy and recommended $12 as its price target on July 11, 2025. JP Morgan downgraded its rating to Underweight for this stock on March 30, 2022. In a note dated August 06, 2021, JP Morgan downgraded an Neutral rating on this stock.
The stock price of Kala Bio Inc [KALA] has been fluctuating between $1.10 and $20.60 over the past year. Currently, Wall Street analysts expect the stock to reach $18.25 within the next 12 months. Kala Bio Inc [NASDAQ: KALA] shares were valued at $1.57 at the most recent close of the market. An investor can expect a potential return of 1062.42% based on the average KALA price forecast.
Analyzing the KALA fundamentals
Gross Profit Margin for this corporation currently stands at -0.28% with Operating Profit Margin at -161.98%, Pretax Profit Margin comes in at -146.56%, and Net Profit Margin reading is -146.56%. To continue investigating profitability, this company’s Return on Assets is posted at -1.03, Equity is -6.86 and Total Capital is -2.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-3.48.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5200 points at the first support level, and at 1.4700 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6600, and for the 2nd resistance point, it is at 1.7500.
Ratios To Look Out For
It’s worth pointing out that Kala Bio Inc [NASDAQ:KALA]’s Current Ratio is 2.10. As well, the Quick Ratio is 2.10, while the Cash Ratio is 1.99.
Transactions by insiders
Recent insider trading involved BAKER BROS. ADVISORS LP, Former 10% owner, that happened on Oct 01 ’25 when 0.51 million shares were sold. Former 10% owner, BAKER BROS. ADVISORS LP completed a deal on Sep 30 ’25 to sell 0.22 million shares. Meanwhile, CHIEF BUSINESS OFFICER Kharabi Darius sold 4511.0 shares on Jun 24 ’25.
